Navigation Links
NxStage® Highlights Non-Medical Emergency Preparedness Guidebook for System One™ Home Hemodialysis Patients
Date:8/26/2011

n the event water or electricity supply is compromised
  • Accessing emergency services and options for transportation  

  • About NxStage Medical

    NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

    Forward-Looking Statements

    This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2011. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact:
    Kristen K. Sheppard, Esq.
    Investor Relations
    ksheppard@nxstage.com


    '/>"/>
    SOURCE NxStage Medical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA
    2. NxStage® Supports Initiative by Patient Advocacy Groups to Educate Policymakers about the Benefits of Frequent Home Hemodialysis
    3. NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
    4. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
    5. NxStage® Names Michael Miller, Jr. President, International
    6. NxStage® to Report First Quarter Fiscal 2011 Financial Results
    7. New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period
    8. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
    9. NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
    10. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
    11. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
    (Date:7/7/2015)... , July 7, 2015 The ... USD 1,197.7 million by 2020, growing at an estimated CAGR ... study by Grand View Research, Inc. Introduction of innovative technologies ... with growing awareness levels pertaining to the advantages of breast ... next six years. In addition, presence of untapped growth opportunities ...
    (Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering of 32,000,000 units. Each unit ... Series A warrant to purchase one share of common ... Investors whose purchase of units in the offering would ...
    Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
    ... SAN RAFAEL, Calif. , Aug. 4 To ... companies have selected New Momentum, the leading SaaS-based anti-counterfeiting solution.  Both ... and shut down violators, their New Momentum solution will play a ... , , ...
    ... Aug. 4 Cytel Inc., premier provider of adaptive clinical trial ... software package for adaptive dose-finding studies based on frequentist or Bayesian methods. , ... The FDA,s recently issued adaptive trial guidelines ... level.  , , , ...
    Cached Medicine Technology:Two More Global Pharmaceutical Companies Choose New Momentum to Stop Counterfeits 2Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 2Cytel Announces Compass® - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies 3
    (Date:7/7/2015)... ... July 07, 2015 , ... ... today that the two firms have merged to form Camber Collective. Camber ... biopharma sectors. The merger combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading ... CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing physical ... have proven to simplify the on-premises deployment of unified remote access and single ...
    (Date:7/7/2015)... ... July 07, 2015 , ... SC&H Group, a leading audit, tax, and ... back to the community through company-wide volunteering efforts. , On an annual basis, in ... to assisting those in need throughout Baltimore and Washington D.C. , This ...
    (Date:7/7/2015)... ... ... Safe Catch is setting revolutionary purity limits for canned tuna as the only ... Markets, Sprouts Farmers Market and Wegmans are some of the first grocers to stock ... mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch tuna for health ...
    (Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud ... Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating patients ... neurological conditions. , After receiving his Bachelor of Science in Biology from the University ...
    Breaking Medicine News(10 mins):Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
    ... department patients about their alcohol use and talking ... patterns is an effective way to lower rates ... a nationwide collaborative study supported by the National ... the Substance Abuse and Mental Health Services Administration ...
    ... Seung Hui,Cho, thousands with schizophrenia or bipolar disorder ... -- Mental health courts are a sign the ... of the nation,s 150 mental health courts, you ... wheelchairs for diabetics after limb,amputation., -- Requiring ...
    ... Shareholders of Subsidiary to Invest in Nyer Medical Group;, ... Nyer Medical Group, BANGOR, Maine, Dec. 26 ... that it has reached agreement with the,minority shareholders of ... remaining 20% interest in the pharmacy chain in,fulfillment of ...
    ... TIKVA, Israel, Dec. 26 012,Smile.Communications (NASDAQ Global ... services in Israel, today,announced that it has been ... deploy an extensive Wireless Internet Access system for ... Under the framework of the contract, 012 ...
    ... of chemotherapy drugs called anthracyclines improves survival in ... had surgery, but it may not offer any ... a study published online December 25 in the ... , Randomized clinical trials have demonstrated that ...
    ... parks and green spaces close to your zip code , ... connection to nature,s beauty that Christmas evergreen in your living ... Federation has developed a Web-based tool to help you find ... in the great outdoors in green places close to your ...
    Cached Medicine News:Health News:Brief intervention helps emergency patients reduce drinking 2Health News:Brief intervention helps emergency patients reduce drinking 3Health News:Treatment Advocacy Center's Top 10 Mental Illness Stories You Didn't Read in 2007 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 3Health News:012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center 2Health News:012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center 3Health News:Anthracyclines improve survival in HER2-positive breast cancer patients 2
    A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
    Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
    ... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
    The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
    Medicine Products: